EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

Subretinal delivery of AAV5-mediated human Pde6b gene ameliorates the disease phenotype in a rat model of retinitis pigmentosa

Hee Jong Kim, Ji Hoon Kwak, Jun Sub Choi, Jin Kim, Seo Yun Moon, Steven Hyun Seung Lee, Heuiran Lee, Keerang Park, Joo Yong Lee, So-Yoon Won

Molecular Vision · 2025

DOI: 10.63500/mv_v31_127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Vision, 2025. Verfasst von Hee Jong Kim und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

A genetic disorder that affects the beta subunit of cyclic guanosine monophosphate-phosphodiesterase type 6 (PDE6B) in humans leads to autosomal recessive retinitis pigmentosa (RP). This condition causes severe vision loss in early life due to fast deterioration of photoreceptors. This study evaluated the therapeutic potential of subretinal delivery of the adeno-associated virus (AAV)5-mediated human Pde6b gene in an RP rat model caused by Pde6b gene knockout (KO).

Methods

We compared the transduction efficiency and tropism of different AAV serotypes (2, 5 and 8) in Pde6b KO rats and found that AAV5 had the highest and most specific expression in photoreceptors. We injected AAV5-Pde6b into the subretinal space of Pde6b KO rats on postnatal day 21. We assessed the protective effects six weeks postinjection by measuring PDE6B protein expression, photoreceptor structure, retinal morphology and thickness, retinal pigment epithelium integrity and visual function.

Results

AAV5-Pde6b treatment ameliorated the disease phenotype in Pde6b KO rats by restoring PDE6B protein expression, preserving photoreceptor structure, improving retinal morphology and thickness, and maintaining retinal pigment epithelium integrity. Functional analysis of vision by scotopic electroretinogram (ERG) and optokinetic nystagmus revealed that AAV5-Pde6b treatment significantly improved the visual function of Pde6b gene KO rats compared with AAV5-GFP-injected Pde6b KO rats.

Conclusions

Our results demonstrate that AAV5-Pde6b may be a potential therapeutic gene candidate for RP caused by Pde6b mutations.

Zitieren

APA

Kim, H. J., Kwak, J. H., Choi, J. S., Kim, J., Moon, S. Y., Lee, S. H. S., Lee, H., Park, K., Lee, J. Y., & Won, S. (2025). Subretinal delivery of AAV5-mediated human Pde6b gene ameliorates the disease phenotype in a rat model of retinitis pigmentosa. Molecular Vision. https://doi.org/10.63500/mv_v31_127

Vancouver

Kim HJ, Kwak JH, Choi JS, Kim J, Moon SY, Lee SHS, et al. Subretinal delivery of AAV5-mediated human Pde6b gene ameliorates the disease phenotype in a rat model of retinitis pigmentosa. Molecular Vision. 2025. doi:10.63500/mv_v31_127

BibTeX
@article{Kim2025,
  author = {Kim, Hee Jong and Kwak, Ji Hoon and Choi, Jun Sub and Kim, Jin and Moon, Seo Yun and Lee, Steven Hyun Seung and Lee, Heuiran and Park, Keerang and Lee, Joo Yong and Won, So-Yoon},
  title = {Subretinal delivery of AAV5-mediated human Pde6b gene ameliorates the disease phenotype in a rat model of retinitis pigmentosa},
  journal = {Molecular Vision},
  year = {2025},
  doi = {10.63500/mv_v31_127}
}
Kostenlos starten →